Closed Solicitation · DEPT OF DEFENSE
AI Summary
The DARPA is seeking proposals for the Medics Autonomously Stopping Hemorrhage (MASH) program, which aims to develop autonomous systems for stabilizing torso hemorrhage without surgical intervention. Proposals must include specific attachments as outlined in the solicitation. This initiative focuses on enhancing pre-hospital hemorrhage control and integrating robotic technology into trauma care.
The purpose of Amendment 1 to DARPA-PS-25-34, the Medics Autonomously Stopping Hemorrhage (MASH) Program Solicitation (PS), is to clarify that proposal abstract submissions must include Attachments A-C. Details are provided in Attachment A, to mirror guidance provided in Section 4.1 of DARPA-PS-25-34. The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals to develop demonstrator autonomous systems to stabilize torso hemorrhage without need of a surgeon in forward medical sites, providing 48+ hours to reach definitive care. The Medics Autonomously Stopping Hemorrhage (MASH) program is seeking approaches that merge multi-modal automated bleed detection and localization with automated, minimally invasive robotic end effectors and sensors. MASHs vision is to push the standard of pre-hospital hemorrhage control to 48 hours; stop lethal forms of torso hemorrhage without a surgeon; and provide minimally invasive surgery (MIS) a path to enter the trauma market and utilize full autonomy.
Medics Autonomously Stopping Hemorrhage (MASH) is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.